These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Exploring fluorine-substituted piperidines as potential therapeutics for diabetes mellitus and Alzheimer's diseases. Mughal EU; Hawsawi MB; Naeem N; Hassan A; Alluhaibi MS; Ali Shah SW; Nazir Y; Sadiq A; Alrafai HA; Ahmed SA Eur J Med Chem; 2024 Jul; 273():116523. PubMed ID: 38795518 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors. Gong Z; Xie Z; Qiu J; Wang G Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182 [TBL] [Abstract][Full Text] [Related]
6. 2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors. Javaid K; Saad SM; Rasheed S; Moin ST; Syed N; Fatima I; Salar U; Khan KM; Perveen S; Choudhary MI Bioorg Med Chem; 2015 Dec; 23(23):7417-21. PubMed ID: 26552899 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of Novel Triazinoindole-Based Thiourea Hybrid: A Study on α-Glucosidase Inhibitors and Their Molecular Docking. Taha M; Alshamrani FJ; Rahim F; Hayat S; Ullah H; Zaman K; Imran S; Khan KM; Naz F Molecules; 2019 Oct; 24(21):. PubMed ID: 31652777 [TBL] [Abstract][Full Text] [Related]
8. Organocatalyzed Novel Synthetic Methodology for Highly Functionalized Piperidines as Potent α-Glucosidase Inhibitors. Farooq A; Shahazadi L; Bajda M; Ullah N; Rauf A; Shahzad SA; Khan AF; Ashraf M; Yar M Arch Pharm (Weinheim); 2016 Sep; 349(9):724-32. PubMed ID: 27489132 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors. Wang G; Wang J; He D; Li X; Li J; Peng Z Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors. Wang G; Peng Z; Wang J; Li X; Li J Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, Molecular Modeling and Biological Evaluation of 5-arylidene-N,N-diethylthiobarbiturates as Potential α-glucosidase Inhibitors. Khan M; Khan S; Ul Mulk A; Ur Rahman A; Wadood A; Shams S; Ashraf M; Rahman J; Khan I; Hameed A; Hussain Z; Khan A; Zaman K; Khan KM; Perveen S Med Chem; 2019; 15(2):175-185. PubMed ID: 30207240 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors. Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567 [TBL] [Abstract][Full Text] [Related]
13. Benzimidazole derivatives as new α-glucosidase inhibitors and in silico studies. Zawawi NK; Taha M; Ahmat N; Wadood A; Ismail NH; Rahim F; Azam SS; Abdullah N Bioorg Chem; 2016 Feb; 64():29-36. PubMed ID: 26637946 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton. Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449 [TBL] [Abstract][Full Text] [Related]
15. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors. Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of 6-hydroxyaurone analogues and evaluation of their α-glucosidase inhibitory and glucose consumption-promoting activity: Development of highly active 5,6-disubstituted derivatives. Sun H; Ding W; Song X; Wang D; Chen M; Wang K; Zhang Y; Yuan P; Ma Y; Wang R; Dodd RH; Zhang Y; Lu K; Yu P Bioorg Med Chem Lett; 2017 Aug; 27(15):3226-3230. PubMed ID: 28651984 [TBL] [Abstract][Full Text] [Related]
17. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study. Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Isatin-Thiazole Derivatives as α-Glucosidase Inhibitors. Xie Z; Wang G; Wang J; Chen M; Peng Y; Li L; Deng B; Chen S; Li W Molecules; 2017 Apr; 22(4):. PubMed ID: 28425975 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, molecular docking and α-glucosidase inhibition of 5-aryl-2-(6'-nitrobenzofuran-2'-yl)-1,3,4-oxadiazoles. Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Saad SM; Khan KM; Nasir A Bioorg Chem; 2016 Jun; 66():117-23. PubMed ID: 27149363 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes. Mohammadi-Khanaposhtani M; Rezaei S; Khalifeh R; Imanparast S; Faramarzi MA; Bahadorikhalili S; Safavi M; Bandarian F; Nasli Esfahani E; Mahdavi M; Larijani B Bioorg Chem; 2018 Oct; 80():288-295. PubMed ID: 29980114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]